{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:22:27Z","timestamp":1792088547320,"version":"4.4.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Departments of Medicine at New York University"},{"DOI":"10.13039\/100007698","name":"University of Florida","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007698","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["ijaaonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.ijantimicag.2013.07.019","type":"journal-article","created":{"date-parts":[[2013,9,21]],"date-time":"2013-09-21T18:02:57Z","timestamp":1379786577000},"page":"571-574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Log reduction of multidrug-resistant Gram-negative bacteria by the neutrophil-derived recombinant bactericidal\/permeability-increasing protein"],"prefix":"10.1016","volume":"42","author":[{"given":"Andrea","family":"Weitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Spotnitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Ovadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M.","family":"Iovine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2013.07.019_bib0005","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.mib.2011.08.002","article-title":"The antibiotic R&D pipeline: an update","volume":"14","author":"Jabes","year":"2011","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.ijantimicag.2013.07.019_bib0010","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cca.2007.07.005","article-title":"The bactericidal\/permeability-increasing protein (BPI) in infection and inflammatory disease","volume":"384","author":"Schultz","year":"2007","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ijantimicag.2013.07.019_bib0015","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1042\/bst0310791","article-title":"Structure of human BPI (bactericidal\/permeability-increasing protein) and implications for related proteins","volume":"31","author":"Beamer","year":"2003","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.ijantimicag.2013.07.019_bib0020","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1177\/009127009903901109","article-title":"Pharmacokinetics of a recombinant modified amino terminal fragment of bactericidal\/permeability-increasing protein (rBPI21) in healthy volunteers","volume":"39","author":"Bauer","year":"1999","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2013.07.019_bib0025","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1128\/AAC.45.3.994-995.2001","article-title":"Polymyxin B-resistant Acinetobacter baumannii clinical isolate susceptible to recombinant BPI and cecropin P1","volume":"45","author":"Urban","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.07.019_bib0030","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1128\/IAI.67.11.5626-5633.1999","article-title":"Endothelial adhesion molecule expression and its inhibition by recombinant bactericidal\/permeability-increasing protein are influenced by the capsulation and lipooligosaccharide structure of Neisseria meningitidis","volume":"67","author":"Dixon","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijantimicag.2013.07.019_bib0035","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4161\/viru.2.1.14752","article-title":"Campylobacter capsule and lipooligosaccharide confer resistance to serum and cationic antimicrobials","volume":"2","author":"Keo","year":"2011","journal-title":"Virulence"},{"key":"10.1016\/j.ijantimicag.2013.07.019_bib0040","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1128\/IAI.68.9.5120-5125.2000","volume":"68","author":"Levy","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijantimicag.2013.07.019_bib0045","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0140-6736(00)02712-4","article-title":"Recombinant bactericidal\/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group","volume":"356","author":"Levin","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2013.07.019_bib0050","doi-asserted-by":"crossref","first-page":"10973","DOI":"10.1073\/pnas.94.20.10973","article-title":"An opsonic function of the neutrophil bactericidal\/permeability-increasing protein depends on both its N- and C-terminal domains","volume":"94","author":"Iovine","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijantimicag.2013.07.019_bib0055","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0140-6736(97)06468-4","article-title":"Preliminary evaluation of recombinant amino-terminal fragment of human bactericidal\/permeability-increasing protein in children with severe meningococcal sepsis","volume":"350","author":"Giroir","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2013.07.019_bib0060","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/00024382-200115020-00008","article-title":"Binding specificity of polymyxin B, BPI, LALF, and anti-deep core\/lipid A monoclonal antibody to lipopolysaccharide partial structures","volume":"15","author":"Kellogg","year":"2001","journal-title":"Shock"},{"key":"10.1016\/j.ijantimicag.2013.07.019_bib0065","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1179\/096805106X118825","article-title":"Diversity of endotoxin and its impact on pathogenesis","volume":"12","author":"Trent","year":"2006","journal-title":"J Endotoxin Res"},{"key":"10.1016\/j.ijantimicag.2013.07.019_bib0070","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1172\/JCI115930","article-title":"Human bactericidal\/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant Gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria","volume":"90","author":"Weiss","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijantimicag.2013.07.019_bib0075","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.1128\/IAI.60.11.4754-4761.1992","article-title":"High-affinity binding of the bactericidal\/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide","volume":"60","author":"Gazzano-Santoro","year":"1992","journal-title":"Infect Immun"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857913003051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857913003051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T01:27:18Z","timestamp":1715995638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857913003051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0924857913003051"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2013.07.019","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Log reduction of multidrug-resistant Gram-negative bacteria by the neutrophil-derived recombinant bactericidal\/permeability-increasing protein","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2013.07.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. and the International Society of Chemotherapy. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}